Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy (ACES-EMB)

NCT06414603 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT06414603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy (ACES-EMB)
Lead sponsor
Natera, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 10, 2024
Completion date
February 28, 2027
Enrollment
250 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplant failure and rejection